These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
206 related items for PubMed ID: 11509952
1. Targeted gene transfer to lymphocytes using murine leukaemia virus vectors pseudotyped with spleen necrosis virus envelope proteins. Engelstädter M, Buchholz CJ, Bobkova M, Steidl S, Merget-Millitzer H, Willemsen RA, Stitz J, Cichutek K. Gene Ther; 2001 Aug; 8(15):1202-6. PubMed ID: 11509952 [Abstract] [Full Text] [Related]
2. MLV-derived retroviral vectors selective for CD4-expressing cells and resistant to neutralization by sera from HIV-infected patients. Stitz J, Steidl S, Merget-Millitzer H, König R, Müller P, Nocken F, Engelstädter M, Bobkova M, Schmitt I, Kurth R, Buchholz CJ, Cichutek K. Virology; 2000 Feb 15; 267(2):229-36. PubMed ID: 10662618 [Abstract] [Full Text] [Related]
3. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1. Stitz J, Buchholz CJ, Engelstädter M, Uckert W, Bloemer U, Schmitt I, Cichutek K. Virology; 2000 Jul 20; 273(1):16-20. PubMed ID: 10891403 [Abstract] [Full Text] [Related]
4. A nuclear localization signal in the matrix of spleen necrosis virus (SNV) does not allow efficient gene transfer into quiescent cells with SNV-derived vectors. Caron MC, Caruso M. Virology; 2005 Aug 01; 338(2):292-6. PubMed ID: 15961134 [Abstract] [Full Text] [Related]
5. The envelope glycoprotein of human endogenous retrovirus HERV-W induces cellular resistance to spleen necrosis virus. Ponferrada VG, Mauck BS, Wooley DP. Arch Virol; 2003 Apr 01; 148(4):659-75. PubMed ID: 12664292 [Abstract] [Full Text] [Related]
7. MLV-10A1 retrovirus pseudotype efficiently transduces primary human CD4+ T lymphocytes. Gladow M, Becker C, Blankenstein T, Uckert W. J Gene Med; 2000 Sep 01; 2(6):409-15. PubMed ID: 11199261 [Abstract] [Full Text] [Related]
8. Suspension packaging cell lines for the simplified generation of T-cell receptor encoding retrovirus vector particles. Reuss S, Biese P, Cosset FL, Takeuchi Y, Uckert W. Gene Ther; 2007 Apr 01; 14(7):595-603. PubMed ID: 17235289 [Abstract] [Full Text] [Related]
9. Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses. Sandrin V, Muriaux D, Darlix JL, Cosset FL. J Virol; 2004 Jul 01; 78(13):7153-64. PubMed ID: 15194792 [Abstract] [Full Text] [Related]
10. A retroviral packaging cell line for pseudotype vectors based on glioma-infiltrating progenitor cells. Fischer YH, Miletic H, Giroglou T, Litwak S, Stenzel W, Neumann H, von Laer D. J Gene Med; 2007 May 01; 9(5):335-44. PubMed ID: 17474071 [Abstract] [Full Text] [Related]
11. Replicating retroviral vectors mediating continuous production and secretion of therapeutic gene products from cancer cells. Finger C, Sun Y, Sanz L, Alvarez-Vallina L, Buchholz CJ, Cichutek K. Cancer Gene Ther; 2005 May 01; 12(5):464-74. PubMed ID: 15692609 [Abstract] [Full Text] [Related]
12. A packaging cell line generating CD4-specific retroviral vectors for efficient gene transfer into primary human T-helper lymphocytes. Thaler S, Schnierle BS. Mol Ther; 2001 Sep 01; 4(3):273-9. PubMed ID: 11545619 [Abstract] [Full Text] [Related]
13. In vivo cell type-specific gene delivery with retroviral vectors that display single chain antibodies. Jiang A, Dornburg R. Gene Ther; 1999 Dec 01; 6(12):1982-7. PubMed ID: 10637449 [Abstract] [Full Text] [Related]
15. A retroviral vector system 'STITCH' in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytes. Weijtens ME, Willemsen RA, Hart EH, Bolhuis RL. Gene Ther; 1998 Sep 01; 5(9):1195-203. PubMed ID: 9930320 [Abstract] [Full Text] [Related]
16. Selective gene transfer to T lymphocytes using coreceptor-specific [MLV(HIV)] pseudotype vectors in a transgenic mouse model. Schüle S, Steidl S, Panitz S, Coulibaly C, Kalinke U, Cichutek K, Schweizer M. Virology; 2006 Jul 20; 351(1):237-47. PubMed ID: 16650881 [Abstract] [Full Text] [Related]
17. Evidence for nonspecific adsorption of targeted retrovirus vector particles to cells. Pizzato M, Blair ED, Fling M, Kopf J, Tomassetti A, Weiss RA, Takeuchi Y. Gene Ther; 2001 Jul 20; 8(14):1088-96. PubMed ID: 11526456 [Abstract] [Full Text] [Related]
18. Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles. Schnierle BS, Moritz D, Jeschke M, Groner B. Gene Ther; 1996 Apr 20; 3(4):334-42. PubMed ID: 8732165 [Abstract] [Full Text] [Related]
19. MuLV packaging systems as models for estimating/measuring retrovirus recombination frequency. Patience C, Takeuch Y, Cosset FL, Weiss RA. Dev Biol (Basel); 2001 Apr 20; 106():169-79; discussion 253-63. PubMed ID: 11761229 [Abstract] [Full Text] [Related]
20. Characterization of an alternative packaging system derived from the cat RD114 retrovirus for gene delivery. Ghani K, Cottin S, de Campos-Lima PO, Caron MC, Caruso M. J Gene Med; 2009 Aug 20; 11(8):664-9. PubMed ID: 19507185 [Abstract] [Full Text] [Related] Page: [Next] [New Search]